Eli Lilly Free Cash Flow 2010-2024 | LLY

Eli Lilly free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Eli Lilly annual free cash flow for 2023 was $0.793B, a 86.17% decline from 2022.
  • Eli Lilly annual free cash flow for 2022 was $5.731B, a 5.36% decline from 2021.
  • Eli Lilly annual free cash flow for 2021 was $6.056B, a 18.48% increase from 2020.

Eli Lilly Free Cash Flow 2010-2024 | LLY

  • Eli Lilly annual free cash flow for 2023 was $0.793B, a 86.17% decline from 2022.
  • Eli Lilly annual free cash flow for 2022 was $5.731B, a 5.36% decline from 2021.
  • Eli Lilly annual free cash flow for 2021 was $6.056B, a 18.48% increase from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$392.1B
Johnson & Johnson (JNJ)$351.2B
AbbVie (ABBV)$318.1B
Merck (MRK)$251.6B
AstraZeneca (AZN)$205.6B
Novartis AG (NVS)$201B
Pfizer (PFE)$151.5B
Sanofi (SNY)$122.6B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B